Humana Inc. (NYSE:HUM) Given Average Rating of "Hold" by Brokerages

Shares of Humana Inc. (NYSE:HUM - Get Free Report) have been assigned an average recommendation of "Hold" from the twenty-three brokerages that are covering the company, MarketBeat.com reports. Sixteen analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $281.4286.

HUM has been the topic of a number of recent analyst reports. Barclays set a $275.00 price objective on Humana and gave the company an "equal weight" rating in a report on Thursday, July 31st. Piper Sandler decreased their price objective on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Bank of America decreased their price objective on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Finally, Cantor Fitzgerald restated a "neutral" rating and set a $290.00 price target on shares of Humana in a research note on Thursday, May 1st.

Humana Price Performance

Shares of HUM stock traded up $1.8540 during trading hours on Monday, reaching $290.1040. The company had a trading volume of 1,247,617 shares, compared to its average volume of 1,729,679. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a fifty day moving average of $244.92 and a 200-day moving average of $253.44. The company has a market capitalization of $34.89 billion, a price-to-earnings ratio of 22.26, a PEG ratio of 1.69 and a beta of 0.44. Humana has a 12-month low of $206.87 and a 12-month high of $382.72.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities analysts anticipate that Humana will post 16.47 earnings per share for the current year.

Institutional Trading of Humana

A number of large investors have recently modified their holdings of HUM. Vanguard Group Inc. raised its stake in Humana by 1.6% in the second quarter. Vanguard Group Inc. now owns 14,199,096 shares of the insurance provider's stock valued at $3,471,395,000 after buying an additional 226,224 shares in the last quarter. Dodge & Cox raised its stake in Humana by 5.6% in the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider's stock valued at $2,775,562,000 after buying an additional 597,705 shares in the last quarter. State Street Corp raised its stake in Humana by 1.1% in the second quarter. State Street Corp now owns 5,377,390 shares of the insurance provider's stock valued at $1,319,334,000 after buying an additional 58,094 shares in the last quarter. Pzena Investment Management LLC grew its holdings in shares of Humana by 6.5% during the second quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider's stock worth $996,664,000 after purchasing an additional 247,744 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Humana by 1.9% during the second quarter. Geode Capital Management LLC now owns 3,130,829 shares of the insurance provider's stock worth $762,233,000 after purchasing an additional 57,267 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.